Loading...
Innogenetics announces definitive closure of GENimmune
03-Jun-2008
Advertisement
Innogenetics announced the final phase of its restructuring plan for the pharma division of GENimmune. In accordance with the collective labor agreement signed on May 8 with its social partners, the remaining 5 labor contracts will shortly be terminated.